miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The microRNA-205 (miR-205) has been shown to be deregulated in prostate cancer (PCa). Here we continue to investigate the prognostic and therapeutic potential of this microRNA. METHODS: The expression of miR-205 is measured by qRT-PCR and in situ hybridisation in a well-documented PCa cohort. An AGO2-based RIP-Chip assay is used to identify targets that are verified with western blots, luciferase reporter assay, ELISA and immunohistochemistry. RESULTS: The expression of miR-205 is inversely correlated to the occurrence of metastases and shortened overall survival, and is lower in castration-resistant PCa patients. The miR-205 expression is mainly localised to the basal cells of benign prostate tissues. Genes regulated by miR-205 are enriched in, for example, the MAPK/ERK, Toll-like receptor and IL-6 signaling pathways. We demonstrate binding of miR-205 to the 3'UTR of androgen receptor (AR) and decrease of both AR transcript and protein levels. This finding was corroborated in the patient cohort were miR-205 expression inversely correlated to AR immunostaining in malignant prostate cells and to serum levels of prostate-specific antigen, an androgen-regulated protein. CONCLUSION: Taken together, these findings imply that miR-205 might have therapeutic potential, especially for the castration resistant and currently untreatable form of PCa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
The impact of microRNAs on protein output
Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008) · Nature · doi:10.1038/nature07242 · Cited by 3,592
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429 · cited 1×
“…miRNA; miR-205; prostate cancer; androgen receptor; CRPC; metastases British Journal of Cancer (2013) 108, 1668–1676 | doi: 10.1038/bjc.2013.131 1668 www.bjcancer.com |DOI:10.1038/bjc.2013.131 protein-coding genes (Farh et al, 2005; Stark et al, 2005; Baek et al, 2008; Selbach et al, 2008).”
InfluentialThe development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326 · cited 3×
“Moreover, miR-205 was lower in castration-resistant patients where AR is frequently upregulated (Feldman and Feldman, 2001), compared with hormone naive patients.”
BackgroundInfluentialThe Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution
Farh, K. K.-H., Grimson, A., Jan, C., Lewis, B. P., Johnston, W. K., Lim, L. P., Burge, C. B., & Bartel, D. P. (2005) · Science · doi:10.1126/science.1121158 · Cited by 1,484
Stark, A., Brennecke, J., Bushati, N., Russell, R. B., & Cohen, S. M. (2005) · Cell · doi:10.1016/j.cell.2005.11.023 · Cited by 1,080
Isolation of microRNA targets by miRNP immunopurification
Easow, G., Teleman, A. A., & Cohen, S. M. (2007) · RNA · doi:10.1261/rna.563707 · Cited by 301 · cited 1×
“The immunopurification protocols were adapted from Easow et al (2007) and Peritz et al (2006).”
MethodTucci, P., Agostini, M., Grespi, F., Markert, E. K., Terrinoni, A., Vousden, K. H., Muller, P. A. J., Dötsch, V., Kehrloesser, S., Sayan, B. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110977109 · Cited by 286 · cited 1×
“Furthermore, miR-205 expression was higher in patients with localised disease compared with patients with distant metastases, confirming earlier results (Gandellini et al, 2009; Tucci et al, 2012).”
Result
Cited by
Larne, O., Östling, P., Haflidadóttir, B. S., Hagman, Z., Aakula, A., Kohonen, P., Kallioniemi, O., Edsjö, A., Bjartell, A., Lilja, H., et al. (2015) · European Urology · doi:10.1016/j.eururo.2014.12.025 · Cited by 38
Self-citationInterplay between steroid signalling and microRNAs: implications for hormone-dependent cancers
Fletcher, C. E., Dart, D. A., & Bevan, C. L. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0208 · Cited by 37
“Hagman et al. (2013) demonstrated that ectopic miR-205 overexpression significantly decreased AR protein levels and activity of an AR 30-UTR reporter in VCaP cells, although this was not recapitulated in LNCaP cells.”
BackgroundRönnau, C. G. H., Fussek, S., Smit, F. P., Aalders, T. W., van Hooij, O., Pinto, P. M. C., Burchardt, M., Schalken, J. A., & Verhaegh, G. W. (2021) · World Journal of Urology · doi:10.1007/s00345-021-03723-4 · Cited by 28
“We also identified miR-205 to be the most downregulated miRNA in CRPC tissue, confirming previous results [14, 19].”
ResultPadmyastuti, A., Sarmiento, M. G., Dib, M., Ehrhardt, J., Schoon, J., Somova, M., Burchardt, M., Roennau, C., & Pinto, P. C. (2023) · Scientific Reports · doi:10.1038/s41598-023-38834-y · Cited by 17
Metadata
- Authors
- Hagman, Z., Haflidadóttir, B. S., Ceder, J. A., Larne, O., Bjartell, A., Lilja, H., Edsjö, A., & Ceder, Y.
- Venue
- British Journal of Cancer
- Published
- 2013-04
- Volume
- 108
- Issue
- 8
- Pages
- 1668-1676
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2035937780
- Cited by
- 127
- References
- 9
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients. https://app.cochat.ai/papers/10.1038/bjc.2013.131
- The paper
- Hagman, Z., Haflidadóttir, B. S., Ceder, J. A., Larne, O., Bjartell, A., Lilja, H., Edsjö, A., & Ceder, Y. (2013). miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients. British Journal of Cancer. https://doi.org/10.1038/bjc.2013.131
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.